🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To observe and evaluate the efficacy and safety of FOLFOX/FOLFIRI± target-d...
Status
Unknown
Location
Liaoning Cancer Hospital & Institute
Start Date
2022-08-01
Trial ID
NCT05797883
Treatments Being Tested
The purpose of the study is to determine the overall response rate of singl...
Status
Terminated
Location
Dana Farber Cancer Institute
Start Date
2016-03
Trial ID
NCT02664961
Treatments Being Tested
A single institution, single arm, two-cohort feasibility trial to evaluate ...
Status
Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2026-03-26
Trial ID
NCT07059494
Treatments Being Tested
Bevacizumab, a humanized monoclonal antibody against vascular endothelial g...
Status
Unknown
Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Start Date
2020-09
Trial ID
NCT02226289
Treatments Being Tested
There are three arms to this study (A, B and C) The purpose of this researc...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2010-04
Trial ID
NCT01112527
Treatments Being Tested
This phase I trial studies the side effects and best dose of ubidecarenone ...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2017-01-04
Trial ID
NCT03020602
Treatments Being Tested
The study is designed to demonstrate that the combination of AG-013736 with...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-03
Trial ID
NCT00615056
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2024-12-10
Trial ID
NCT06704724
A study of Avastin (bevacizumab) in combination chemotherapy in patients wi...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT01131078
Treatments Being Tested
The ONTOP study is a prospective, single-arm, open-label phase II clinical ...
Status
Recruiting
Location
Shanghai Pudong Hospital
Start Date
2025-08-31
Trial ID
NCT07106034